Spaces:
Running
Running
File size: 24,658 Bytes
9754890 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 |
{
"cells": [
{
"cell_type": "code",
"execution_count": 3,
"metadata": {},
"outputs": [
{
"name": "stdout",
"output_type": "stream",
"text": [
"Fetching data from: https://clinicaltrials.gov/api/v2/studies?query.titles=Stomach cancer SEARCH[Location](AREA[LocationCountry]Japan AND AREA[LocationStatus]Recruiting)&pageSize=100\n"
]
}
],
"source": [
"from langchain_community.agent_toolkits import create_sql_agent\n",
"from langchain_openai import ChatOpenAI\n",
"from langchain_groq import ChatGroq\n",
"from langchain_core.prompts import ChatPromptTemplate\n",
"from langchain_core.pydantic_v1 import BaseModel, Field\n",
"import pandas as pd\n",
"from pydantic import BaseModel, Field\n",
"\n",
"from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
"from langchain_community.vectorstores import Chroma\n",
"from langchain.embeddings import HuggingFaceEmbeddings\n",
"from langchain_core.runnables import RunnablePassthrough\n",
"from langchain_core.output_parsers import StrOutputParser\n",
"\n",
"\n",
"gpt = ChatOpenAI(model=\"gpt-3.5-turbo\", temperature=0)\n",
"#agent_gpt_executor = create_sql_agent(gpt, db=db, agent_type=\"tool-calling\", verbose=True)\n",
"\n",
"## make database\n",
"from langchain_community.utilities import SQLDatabase\n",
"from sqlalchemy import create_engine\n",
"\n",
"from langchain.prompts import ChatPromptTemplate\n",
"from langchain.schema import SystemMessage\n",
"from langchain_core.prompts import MessagesPlaceholder\n",
"#agent_groq_executor = create_sql_agent(llm, db=db, agent_type=\"tool-calling\", verbose=True)\n",
"\n",
"from OpenAITools.FetchTools import fetch_clinical_trials, fetch_clinical_trials_jp\n",
"from OpenAITools.CrinicalTrialTools import QuestionModifierEnglish, TumorNameExtractor, SimpleClinicalTrialAgent,GraderAgent,LLMTranslator,generate_ex_question_English\n",
"\n",
"groq = ChatGroq(model_name=\"llama3-70b-8192\", temperature=0)\n",
"#agent_groq_executor = create_sql_agent(groq, db=db, agent_type=\"tool-calling\", verbose=True)\n",
"\n",
"age = \"65\"\n",
"sex =\"男性\"\n",
"tumor_type =\"胃癌\"\n",
"#tumor_type = \"gastric cancer\"\n",
"GeneMutation =\"HER2\"\n",
"Meseable = \"有り\"\n",
"Biopsiable = \"有り\"\n",
"NCTID = 'NCT06441994'\n",
"\n",
"#Define extractor\n",
"Translator = LLMTranslator(groq)\n",
"TumorName = Translator.translate(tumor_type)\n",
"\n",
"#Make db\n",
"df = fetch_clinical_trials(TumorName)\n",
"# 新しい列を追加\n",
"df['AgentJudgment'] = None\n",
"df['AgentGrade'] = None\n",
"#df = df.iloc[:5, :]\n",
"NCTIDs = list(df['NCTID' ])\n",
"\n",
"#Define agents\n",
"#modifier = QuestionModifierEnglish(groq)\n",
"CriteriaCheckAgent = SimpleClinicalTrialAgent(groq)\n",
"grader_agent = GraderAgent(groq)"
]
},
{
"cell_type": "code",
"execution_count": 4,
"metadata": {},
"outputs": [],
"source": [
"ex_question = generate_ex_question_English(age, sex, TumorName, GeneMutation, Meseable, Biopsiable)"
]
},
{
"cell_type": "code",
"execution_count": 5,
"metadata": {},
"outputs": [
{
"name": "stdout",
"output_type": "stream",
"text": [
"The patient is not eligible for this clinical trial because the trial is for metastatic breast cancer (mBC) or metastatic gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, or esophageal adenocarcinoma (mGEAC), and the patient has stomach cancer, which is not explicitly mentioned in the inclusion criteria.\n",
"no\n",
"The patient is eligible for this clinical trial based on the provided information, as they meet the inclusion criteria (age, measurable tumor, biopsiable tumor, and HER2 gene mutation) and do not have any of the exclusion criteria mentioned.\n",
"yes\n",
"The patient is eligible for this clinical trial based on the provided information, as he has a known HER2 gene mutation and a measurable and biopsiable tumor. However, I do not know if he meets the other inclusion criteria, such as adequate bone marrow, renal, and liver function, and performance status.\n",
"unclear\n",
"The 65-year-old male patient with Stomach cancer is eligible for this clinical trial based on the provided criteria, as he meets the inclusion criteria (age, disease characteristics, measurable tumor, and HER2-positive status) and does not have any of the listed exclusion criteria.\n",
"yes\n",
"The patient is eligible for this clinical trial based on the provided criteria, as the patient has a biopsy-confirmed diagnosis of stomach cancer (gastric adenocarcinoma), is 65 years old (meeting the age criterion), and has a biopsiable tumor.\n",
"yes\n",
"The patient is eligible for this clinical trial based on the provided criteria. The patient meets the inclusion criteria for gastric/GEJ cancer, has a measurable tumor, and has a biopsiable tumor. The patient's HER2 mutation is not a exclusion criterion. However, the patient's age (65) is not explicitly mentioned as an inclusion or exclusion criterion, but it is likely that the patient is considered an adult according to local regulation.\n",
"yes\n",
"I do not know if the patient is eligible for this clinical trial because the criteria do not mention age or cancer type as inclusion or exclusion criteria, and there is no information about the patient's H. pylori status.\n",
"unclear\n",
"The patient is not eligible for this clinical trial because the patient's tumor has a HER2 mutation, whereas the trial requires a KRAS wild type (wt) amplification or a KRAS G12V mutation.\n",
"no\n",
"The patient is not eligible for this clinical trial because the patient has stomach cancer, but the trial is specific to gastric cancer with malignant ascites or pancreatic cancer with malignant ascites, and there is no mention of malignant ascites in the patient's condition.\n",
"no\n",
"The patient is eligible for this clinical trial based on the provided criteria, as they meet the inclusion criteria (unresectable or recurrent gastric cancer, age over 20, and measurable tumor) and do not have any of the exclusion criteria mentioned.\n",
"yes\n",
"The patient is not eligible for this clinical trial because the patient has a known HER2 gene mutation, and the exclusion criteria specifically state that HER2 positive gastric or GEJ adenocarcinoma is an exclusion criterion.\n",
"no\n",
"The 65-year-old male patient with Stomach cancer is eligible for this clinical trial based on the provided information, as he meets the inclusion criteria (HER2-positive, measurable tumor, and biopsiable tumor) and does not have any obvious exclusion criteria mentioned.\n",
"yes\n",
"The patient is not eligible for this clinical trial because they have a known HER2 gene mutation, which is an exclusion criterion.\n",
"no\n"
]
}
],
"source": [
"for nct_id in NCTIDs:\n",
" TargetCriteria = df.loc[df['NCTID'] == nct_id, 'Eligibility Criteria'].values[0]\n",
" AgentJudgment = CriteriaCheckAgent.evaluate_eligibility(TargetCriteria, ex_question)\n",
" print(AgentJudgment)\n",
"\n",
" AgentGrade = grader_agent.evaluate_eligibility(AgentJudgment)\n",
" print(AgentGrade)\n",
" # NCTIDに一致する行を見つけて更新\n",
" df.loc[df['NCTID'] == nct_id, 'AgentJudgment'] = AgentJudgment\n",
" df.loc[df['NCTID'] == nct_id, 'AgentGrade'] = AgentGrade"
]
},
{
"cell_type": "code",
"execution_count": null,
"metadata": {},
"outputs": [],
"source": []
},
{
"cell_type": "code",
"execution_count": 7,
"metadata": {},
"outputs": [],
"source": [
" # 列を指定した順に並び替え\n",
"columns_order = ['NCTID', 'AgentGrade', 'Title', 'AgentJudgment', 'Japanes Locations', \n",
" 'Primary Completion Date', 'Cancer', 'Summary', 'Eligibility Criteria']\n",
"df = df[columns_order] "
]
},
{
"cell_type": "code",
"execution_count": 8,
"metadata": {},
"outputs": [
{
"data": {
"text/html": [
"<div>\n",
"<style scoped>\n",
" .dataframe tbody tr th:only-of-type {\n",
" vertical-align: middle;\n",
" }\n",
"\n",
" .dataframe tbody tr th {\n",
" vertical-align: top;\n",
" }\n",
"\n",
" .dataframe thead th {\n",
" text-align: right;\n",
" }\n",
"</style>\n",
"<table border=\"1\" class=\"dataframe\">\n",
" <thead>\n",
" <tr style=\"text-align: right;\">\n",
" <th></th>\n",
" <th>NCTID</th>\n",
" <th>AgentGrade</th>\n",
" <th>Title</th>\n",
" <th>AgentJudgment</th>\n",
" <th>Japanes Locations</th>\n",
" <th>Primary Completion Date</th>\n",
" <th>Cancer</th>\n",
" <th>Summary</th>\n",
" <th>Eligibility Criteria</th>\n",
" </tr>\n",
" </thead>\n",
" <tbody>\n",
" <tr>\n",
" <th>0</th>\n",
" <td>NCT06324357</td>\n",
" <td>no</td>\n",
" <td>Beamion BCGC-1: A Study to Find a Suitable Dos...</td>\n",
" <td>The patient is not eligible for this clinical ...</td>\n",
" <td>ku, shi</td>\n",
" <td>2027-02-22</td>\n",
" <td>Metastatic Breast Cancer, Metastatic Gastric A...</td>\n",
" <td>This study is open to adults aged 18 years and...</td>\n",
" <td>Inclusion Criteria:\\n\\n* Signed and dated writ...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>1</th>\n",
" <td>NCT06490055</td>\n",
" <td>yes</td>\n",
" <td>Predicting the Efficacy in Advanced Gastric Ca...</td>\n",
" <td>The patient is eligible for this clinical tria...</td>\n",
" <td>Kurashiki</td>\n",
" <td>2025-12-31</td>\n",
" <td>Gastric Cancer, Chemotherapy Effect, Paclitaxe...</td>\n",
" <td>With advances in chemotherapy for gastric canc...</td>\n",
" <td>Inclusion Criteria:\\n\\n1. unresectable or recu...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>2</th>\n",
" <td>NCT05002127</td>\n",
" <td>unclear</td>\n",
" <td>A Study of Evorpacept (ALX148) in Patients wit...</td>\n",
" <td>The patient is eligible for this clinical tria...</td>\n",
" <td>Chiba, Fukuoka, Gifu, Kumamoto, Kyoto, Nagasak...</td>\n",
" <td>2026-07</td>\n",
" <td>Gastric Cancer, Gastroesophageal Junction Aden...</td>\n",
" <td>A Phase 2/3 Study of Evorpacept (ALX148) in Co...</td>\n",
" <td>Inclusion Criteria:\\n\\n* HER2-overexpressing a...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>3</th>\n",
" <td>NCT04379596</td>\n",
" <td>yes</td>\n",
" <td>Ph1b/2 Study of the Safety and Efficacy of T-D...</td>\n",
" <td>The 65-year-old male patient with Stomach canc...</td>\n",
" <td>Kashiwa, gun, ku, shi</td>\n",
" <td>2026-07-30</td>\n",
" <td>Gastric Cancer</td>\n",
" <td>DESTINY-Gastric03 will investigate the safety,...</td>\n",
" <td>Inclusion criteria:\\n\\n1. Male and female part...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>4</th>\n",
" <td>NCT05205343</td>\n",
" <td>yes</td>\n",
" <td>Trans-Pacific Multicenter Collaborative Study ...</td>\n",
" <td>The patient is eligible for this clinical tria...</td>\n",
" <td>Tokyo</td>\n",
" <td>2026-05-31</td>\n",
" <td>Gastrostomy, Gastric, GastroEsophageal Cancer</td>\n",
" <td>To compare the symptoms of patients who have a...</td>\n",
" <td>Inclusion Criteria:\\n\\n1. Able to speak and re...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>5</th>\n",
" <td>NCT05365581</td>\n",
" <td>yes</td>\n",
" <td>A Study of ASP2138 Given by Itself or Given Wi...</td>\n",
" <td>The patient is eligible for this clinical tria...</td>\n",
" <td>Kashiwa, Nagoya, Osakasayama, Suita, Yokohama, ku</td>\n",
" <td>2026-10-31</td>\n",
" <td>Gastric Adenocarcinoma, Gastroesophageal Junct...</td>\n",
" <td>Claudin 18.2 protein, or CLDN18.2 is a protein...</td>\n",
" <td>Inclusion Criteria:\\n\\n* Participant is consid...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>6</th>\n",
" <td>NCT00197470</td>\n",
" <td>unclear</td>\n",
" <td>Cytokine Gene Polymorphisms in Gastric Diseases</td>\n",
" <td>I do not know if the patient is eligible for t...</td>\n",
" <td>Hamamatsu</td>\n",
" <td>Unknown Date</td>\n",
" <td>Gastric Ulcer, Duodenal Ulcer, Gastric Cancer</td>\n",
" <td>Recently, cytokine polymorphisms are considere...</td>\n",
" <td>Inclusion Criteria:\\n\\n-\\n\\nExclusion Criteria...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>7</th>\n",
" <td>NCT06056024</td>\n",
" <td>no</td>\n",
" <td>A Study to Test How Well Different Doses of BI...</td>\n",
" <td>The patient is not eligible for this clinical ...</td>\n",
" <td>Kashiwa, ku</td>\n",
" <td>2027-05-26</td>\n",
" <td>Solid Tumor, KRAS Mutation</td>\n",
" <td>This study is open to adults with advanced can...</td>\n",
" <td>Inclusion Criteria:\\n\\n1. Patients with pathol...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>8</th>\n",
" <td>NCT05438459</td>\n",
" <td>no</td>\n",
" <td>GAIA-102 Intraperitoneal Administration in Pat...</td>\n",
" <td>The patient is not eligible for this clinical ...</td>\n",
" <td>shi</td>\n",
" <td>2026-12-31</td>\n",
" <td>Gastric Cancer, Pancreatic Cancer</td>\n",
" <td>Phase I Part :\\n\\nConfirm the safety of GAIA-1...</td>\n",
" <td>Inclusion Criteria:\\n\\n1. Unresectable, advanc...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>9</th>\n",
" <td>NCT06490159</td>\n",
" <td>yes</td>\n",
" <td>Predicting Peripheral Neuropathy of Paclitaxel...</td>\n",
" <td>The patient is eligible for this clinical tria...</td>\n",
" <td>Kurashiki</td>\n",
" <td>2025-12-31</td>\n",
" <td>Gastric Cancer, Chemotherapy-induced Periphera...</td>\n",
" <td>Although advances in chemotherapy have improve...</td>\n",
" <td>Inclusion Criteria:\\n\\n1. unresectable or recu...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>10</th>\n",
" <td>NCT06038578</td>\n",
" <td>no</td>\n",
" <td>A Study of TRK-950 When Used in Combination Wi...</td>\n",
" <td>The patient is not eligible for this clinical ...</td>\n",
" <td>Chuo Ku, Kashiwa, Ku</td>\n",
" <td>2025-08-31</td>\n",
" <td>Gastric Adenocarcinoma, Gastric Cancer, Gastro...</td>\n",
" <td>This study will assess the efficacy, safety, o...</td>\n",
" <td>Inclusion Criteria:\\n\\n* Histologically or cyt...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>11</th>\n",
" <td>NCT05152147</td>\n",
" <td>yes</td>\n",
" <td>A Study of Zanidatamab in Combination With Che...</td>\n",
" <td>The 65-year-old male patient with Stomach canc...</td>\n",
" <td>Cho, Chuo Ku, Hirakata, Ina, Ku, Matsuyama, Na...</td>\n",
" <td>2024-12-31</td>\n",
" <td>Gastric Neoplasms, Gastroesophageal Adenocarci...</td>\n",
" <td>This study is being done to find out if zanida...</td>\n",
" <td>Inclusion Criteria:\\n\\n* Histologically confir...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>12</th>\n",
" <td>NCT05322577</td>\n",
" <td>no</td>\n",
" <td>A Study Evaluating Bemarituzumab in Combinatio...</td>\n",
" <td>The patient is not eligible for this clinical ...</td>\n",
" <td>Shi, gun, ku, shi</td>\n",
" <td>2026-03-17</td>\n",
" <td>Gastric Cancer, Gastroesophageal Junction Cancer</td>\n",
" <td>The main objectives of this study are to evalu...</td>\n",
" <td>Inclusion Criteria:\\n\\n* Adults with unresecta...</td>\n",
" </tr>\n",
" </tbody>\n",
"</table>\n",
"</div>"
],
"text/plain": [
" NCTID AgentGrade Title \\\n",
"0 NCT06324357 no Beamion BCGC-1: A Study to Find a Suitable Dos... \n",
"1 NCT06490055 yes Predicting the Efficacy in Advanced Gastric Ca... \n",
"2 NCT05002127 unclear A Study of Evorpacept (ALX148) in Patients wit... \n",
"3 NCT04379596 yes Ph1b/2 Study of the Safety and Efficacy of T-D... \n",
"4 NCT05205343 yes Trans-Pacific Multicenter Collaborative Study ... \n",
"5 NCT05365581 yes A Study of ASP2138 Given by Itself or Given Wi... \n",
"6 NCT00197470 unclear Cytokine Gene Polymorphisms in Gastric Diseases \n",
"7 NCT06056024 no A Study to Test How Well Different Doses of BI... \n",
"8 NCT05438459 no GAIA-102 Intraperitoneal Administration in Pat... \n",
"9 NCT06490159 yes Predicting Peripheral Neuropathy of Paclitaxel... \n",
"10 NCT06038578 no A Study of TRK-950 When Used in Combination Wi... \n",
"11 NCT05152147 yes A Study of Zanidatamab in Combination With Che... \n",
"12 NCT05322577 no A Study Evaluating Bemarituzumab in Combinatio... \n",
"\n",
" AgentJudgment \\\n",
"0 The patient is not eligible for this clinical ... \n",
"1 The patient is eligible for this clinical tria... \n",
"2 The patient is eligible for this clinical tria... \n",
"3 The 65-year-old male patient with Stomach canc... \n",
"4 The patient is eligible for this clinical tria... \n",
"5 The patient is eligible for this clinical tria... \n",
"6 I do not know if the patient is eligible for t... \n",
"7 The patient is not eligible for this clinical ... \n",
"8 The patient is not eligible for this clinical ... \n",
"9 The patient is eligible for this clinical tria... \n",
"10 The patient is not eligible for this clinical ... \n",
"11 The 65-year-old male patient with Stomach canc... \n",
"12 The patient is not eligible for this clinical ... \n",
"\n",
" Japanes Locations Primary Completion Date \\\n",
"0 ku, shi 2027-02-22 \n",
"1 Kurashiki 2025-12-31 \n",
"2 Chiba, Fukuoka, Gifu, Kumamoto, Kyoto, Nagasak... 2026-07 \n",
"3 Kashiwa, gun, ku, shi 2026-07-30 \n",
"4 Tokyo 2026-05-31 \n",
"5 Kashiwa, Nagoya, Osakasayama, Suita, Yokohama, ku 2026-10-31 \n",
"6 Hamamatsu Unknown Date \n",
"7 Kashiwa, ku 2027-05-26 \n",
"8 shi 2026-12-31 \n",
"9 Kurashiki 2025-12-31 \n",
"10 Chuo Ku, Kashiwa, Ku 2025-08-31 \n",
"11 Cho, Chuo Ku, Hirakata, Ina, Ku, Matsuyama, Na... 2024-12-31 \n",
"12 Shi, gun, ku, shi 2026-03-17 \n",
"\n",
" Cancer \\\n",
"0 Metastatic Breast Cancer, Metastatic Gastric A... \n",
"1 Gastric Cancer, Chemotherapy Effect, Paclitaxe... \n",
"2 Gastric Cancer, Gastroesophageal Junction Aden... \n",
"3 Gastric Cancer \n",
"4 Gastrostomy, Gastric, GastroEsophageal Cancer \n",
"5 Gastric Adenocarcinoma, Gastroesophageal Junct... \n",
"6 Gastric Ulcer, Duodenal Ulcer, Gastric Cancer \n",
"7 Solid Tumor, KRAS Mutation \n",
"8 Gastric Cancer, Pancreatic Cancer \n",
"9 Gastric Cancer, Chemotherapy-induced Periphera... \n",
"10 Gastric Adenocarcinoma, Gastric Cancer, Gastro... \n",
"11 Gastric Neoplasms, Gastroesophageal Adenocarci... \n",
"12 Gastric Cancer, Gastroesophageal Junction Cancer \n",
"\n",
" Summary \\\n",
"0 This study is open to adults aged 18 years and... \n",
"1 With advances in chemotherapy for gastric canc... \n",
"2 A Phase 2/3 Study of Evorpacept (ALX148) in Co... \n",
"3 DESTINY-Gastric03 will investigate the safety,... \n",
"4 To compare the symptoms of patients who have a... \n",
"5 Claudin 18.2 protein, or CLDN18.2 is a protein... \n",
"6 Recently, cytokine polymorphisms are considere... \n",
"7 This study is open to adults with advanced can... \n",
"8 Phase I Part :\\n\\nConfirm the safety of GAIA-1... \n",
"9 Although advances in chemotherapy have improve... \n",
"10 This study will assess the efficacy, safety, o... \n",
"11 This study is being done to find out if zanida... \n",
"12 The main objectives of this study are to evalu... \n",
"\n",
" Eligibility Criteria \n",
"0 Inclusion Criteria:\\n\\n* Signed and dated writ... \n",
"1 Inclusion Criteria:\\n\\n1. unresectable or recu... \n",
"2 Inclusion Criteria:\\n\\n* HER2-overexpressing a... \n",
"3 Inclusion criteria:\\n\\n1. Male and female part... \n",
"4 Inclusion Criteria:\\n\\n1. Able to speak and re... \n",
"5 Inclusion Criteria:\\n\\n* Participant is consid... \n",
"6 Inclusion Criteria:\\n\\n-\\n\\nExclusion Criteria... \n",
"7 Inclusion Criteria:\\n\\n1. Patients with pathol... \n",
"8 Inclusion Criteria:\\n\\n1. Unresectable, advanc... \n",
"9 Inclusion Criteria:\\n\\n1. unresectable or recu... \n",
"10 Inclusion Criteria:\\n\\n* Histologically or cyt... \n",
"11 Inclusion Criteria:\\n\\n* Histologically confir... \n",
"12 Inclusion Criteria:\\n\\n* Adults with unresecta... "
]
},
"execution_count": 8,
"metadata": {},
"output_type": "execute_result"
}
],
"source": [
"df"
]
},
{
"cell_type": "code",
"execution_count": null,
"metadata": {},
"outputs": [],
"source": []
}
],
"metadata": {
"kernelspec": {
"display_name": "gradio",
"language": "python",
"name": "python3"
},
"language_info": {
"codemirror_mode": {
"name": "ipython",
"version": 3
},
"file_extension": ".py",
"mimetype": "text/x-python",
"name": "python",
"nbconvert_exporter": "python",
"pygments_lexer": "ipython3",
"version": "3.12.3"
}
},
"nbformat": 4,
"nbformat_minor": 2
}
|